Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasobol for Testosterone Replacement in Hypogonadal Men
NCT00975650Phase 2Completed
- Sponsor
- Acerus Pharmaceuticals
- Start
- Aug 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of testosterone in Hypogonadism (4 arms), sponsored by Acerus Pharmaceuticals. Primary endpoints: Serum Testosterone Ln-Cmax, Serum Testosterone Ln-AUCt and 5 more. Started Aug 2009; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00975650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975650.